Table 1. Correlation of Plasma Levels of... | American Society of Hematology

Table 1.

Correlation of Plasma Levels of nm23-H1 With Clinical and Prognostic Characteristics in Intermediate- and High-Grade Non-Hodgkin’s Lymphoma

Characteristic	No. of Patients	Mediannm23-H1 Level (ng/mL)	P Value^*
Age at diagnosis (yr)
<60	59	29.1	.5435
≥60	90	30.5
Gender
Male	84	29.0	1.0000
Female	65	30.4
WHO performance status
0, 1	131	28.4	.0069
2 ∼ 4	18	58.8
Serum LDH level
Normal	39	23.2	.0926
>Normal	110	33.4
Ann Arbor stage
I, II	61	21.3	.0176
III, IV	88	35.2
Extranodal sites
≤1	141	29.6	.4310
>1	8	52.3
IPI
Low/low-intermediate	100	28.7	.2429
High-intermediate/high	49	32.5
Immunophenotype
T	37	39.1	.0145
B	112	28.1
Soluble IL-2 receptor level (U/mL)
<1,000	83	24.4	.0018
≥1,000	66	41.1
Soluble CD44 level (ng/mL)
<1,000	95	28.2	.4932
≥1,000	17	35.0
Therapeutic response
CR	126	37.4	.0001
PR + nonresponse	23	93.6

Characteristic	No. of Patients	Mediannm23-H1 Level (ng/mL)	P Value^*
Age at diagnosis (yr)
<60	59	29.1	.5435
≥60	90	30.5
Gender
Male	84	29.0	1.0000
Female	65	30.4
WHO performance status
0, 1	131	28.4	.0069
2 ∼ 4	18	58.8
Serum LDH level
Normal	39	23.2	.0926
>Normal	110	33.4
Ann Arbor stage
I, II	61	21.3	.0176
III, IV	88	35.2
Extranodal sites
≤1	141	29.6	.4310
>1	8	52.3
IPI
Low/low-intermediate	100	28.7	.2429
High-intermediate/high	49	32.5
Immunophenotype
T	37	39.1	.0145
B	112	28.1
Soluble IL-2 receptor level (U/mL)
<1,000	83	24.4	.0018
≥1,000	66	41.1
Soluble CD44 level (ng/mL)
<1,000	95	28.2	.4932
≥1,000	17	35.0
Therapeutic response
CR	126	37.4	.0001
PR + nonresponse	23	93.6

Abbreviation: LDH, lactate dehydrogenase.

Mann-Whitney test.